NEW YORK, February 28, 2017 /PRNewswire/ --
On Monday, February 27, 2017, US markets
Draper, Utah headquartered HealthEquity Inc.'s stock advanced 4.20%, to close the day at $43.96. The stock recorded a trading volume of 424,599 shares. HealthEquity's shares gained 1.78% in the previous three months and 114.65% in the past one year. The Company's shares are trading 23.90% above its 200-day moving average. Shares of the Company, which provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the US, are trading at a PE ratio of 102.95. Additionally, the stock has a Relative Strength Index (RSI) of 50.68. Visit us today and download your complete report on HQY for free at:
On Monday, shares in Arlington, Virginia headquartered Evolent Health Inc. ended the session 1.72% lower at $20.00 with a total volume of 387,053 shares traded. Evolent Health's shares have surged 10.80% in the last one month and 102.43% in the previous one year. The stock is trading 13.40% above its 50-day moving average and 0.68% above its 200-day moving average. Moreover, shares of the Company, which through its subsidiary, Evolent Health LLC provides healthcare delivery and payment solutions in the US, have an RSI of 62.56. The complimentary research report on EVH can be accessed at:
On Monday, shares in Charlotte, North Carolina headquartered Premier Inc. recorded a trading volume of 922,781 shares, which was above their three months average volume of 532,370 shares. The stock ended the day 2.27% higher at $32.05. Shares of the Company, which together with its subsidiaries, operates as a healthcare improvement company in the US, are trading at a PE ratio of 5.70. Premier's stock has advanced 1.71% in the last one month and 6.69% in the previous three months. The Company is trading above its 50-day and 200-day moving averages by 2.14% and 1.00%, respectively. Furthermore, Premier's shares have an RSI of 57.04. Register for free on Stock-Callers.com and download the PDF research report on PINC at:
New York headquartered Medidata Solutions Inc.'s stock finished Monday's session 1.78% higher at $56.59 with a total volume of 479,503 shares traded. Over the last one month and the previous three months, Medidata Solutions' shares have gained 13.27% and 1.69%, respectively. Furthermore, the stock has surged 62.38% in the past one year. The Company's shares are trading above its 50-day and 200-day moving averages by 9.10% and 10.85%, respectively. Shares of Medidata Solutions, which provides cloud-based solutions for life sciences worldwide, are trading at a PE ratio of 111.84. Moreover, the stock has an RSI of 63.11.
On February 10th, 2017, research firm SunTrust upgraded the Company's stock rating from 'Neutral' to 'Buy'. Get free access to your research report on MDSO at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: +44 330 808 3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
Urinary retention is a condition where a person is unable to voluntarily empty the urinary bladder ...
Hashimoto's thyroiditis is an autoimmune disorder of the thyroid causing hypothyroidism. Synthetic ...
Strokes occur when blood flow to an area of the brain is cut off. It is imperitive to detect the ...View All